Crdf stocktwits.

Track Perspective Therapeutics Inc (CATX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Stock Price Forecast. The 2 analysts with 12-month price forecasts for Cardiff Oncology stock have an average target of 10.5, with a low estimate of 7.00 and a high estimate of 14. The average target predicts an increase …3 days ago · Cardiff Oncology Inc. Watch list. NEW. Set a price target alert. After Hours. Last Updated: May 2, 2024 7:58 p.m. EDT Delayed quote. $ 3.9700. -0.51 -11.38% After Hours Volume: 162.75K. Advanced... Find the latest Cardiff Oncology, Inc. (CRDF) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Track Cardio Diagnostics Holdings Inc (CDIO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

View the latest Cardiff Oncology Inc. (CRDF) stock price, news, historical charts, analyst ratings and financial information from WSJ./PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug... CRDF : 4.07 (+2.01%) Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update PR Newswire - Wed Aug 9, 2023

Cardiff Oncology First Quarter 2024 Financial Results and Corporate Updates on May 2, 2024 at 4:30 p.m. ET/1:30 p.m. PT. Our lead asset is onvansertib, a PLK1 inhibitor that …

52 Week Low Date 11/10/23. Market Cap 196.279M. Shares Out 44.71M. 10 Day Average Volume 0.62M. Dividend -. Dividend Yield -. Beta 1.98. YTD % Change 193.24. CRDF Stock 12 Month Forecast. $10.50. (140.27% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Cardiff Oncology in the last 3 months. The average price target is $10.50 with a high forecast of $14.00 and a low forecast of $7.00. The average price target represents a 140.27% change from the last price of $4.37. CRDF market cap is currently $81.31M and has a P/E ratio of -1.99. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their ...Cardiff Oncology, Inc. (NASDAQ:CRDF) insiders placed bullish bets worth US$681k in the last 12 months. (Simply Wall St.) +6.48%. Mar-08-22 04:45PM. Cardiff Oncology Announces Upcoming Poster Presentations at the AACR Annual Meeting.

Stock analysis for Cardiff Oncology Inc (CRDF:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

View Cardiff Oncology, Inc. CRDF stock quote prices, financial information, real-time forecasts, and company news from CNN.

5 days ago · About CRDF. Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies to treat various cancers in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor to treatment a range of solid tumor cancers and KRAS/NRAS-mutated metastatic colorectal and metastatic pancreatic cancer, as well as investigator-initiated trials in ... Excessive Up trend, not sustainable, occurs only 5% of the time, expect trend to turn sideways or lower.At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Track eHealth Inc (EHTH) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsCardiff Oncology, Inc. Trovagene, Inc. is a clinical-stage, precision cancer medicine oncology therapeutics company, which engages in the development of drugs that target cell division (mitosis), for the treatment of various cancers …

Trending. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result ...Real-Time Quotes After-Market Quotes. Get the latest updates on Cardiff Oncology, Inc. Common Stock (CRDF) pre market trades, share volumes, and more. Make informed investments with Nasdaq.Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Se... Here's a roundup of top develo...CRDF Stocktwits Stats - WallStreetOdds. $4.27. -$0.08 | -1.8%. Real-Time Price. Overview Odds Analyst Ratings Earnings StockTwits Stats DCF Model Historic Returns Seasonality. StockTwits Overview (with Rank) Sentiment. 43. 769th.CRDF Stock 12 Month Forecast. $10.50. (140.27% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Cardiff Oncology in the last 3 months. The average price target is $10.50 with a high forecast of $14.00 and a low forecast of $7.00. The average price target represents a 140.27% change from the last price of $4.37.Track CorMedix Inc (CRMD) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Track Cornerstone Total Return Fund Inc. (CRF) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsA price increase of 83.5% over the past four weeks ensures that the trend is still in place for the stock of this molecular diagnostic company. Moreover, CRDF is currently trading at 80.3% of its 52-week High-Low Range, hinting that it can be on the verge of a breakout. Looking at the fundamentals, the stock currently carries a Zacks Rank #2 ...

Enter your email address below for free access to our Cardiff Oncology, Inc. (CRDF) research center and poll results. Cardiff Oncology, Inc. NASDAQ:CRDF. $4.36 USD $0.01 (0.23%) Volume 423.82K. Average Volume 1.84M. Market Capitalization $194.79M. P/E Ratio-4.80. Dividend Yield 0.00%. Price Target $ Year High $6.42. Year Low $0.94. Analyze Stocktwits Mentions for Cardiff Oncology and gain a competitive edge with unique and comprehensive information. Track Ardelyx Inc (ARDX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack fuboTV Inc (FUBO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors52 Week Low Date 11/10/23. Market Cap 196.279M. Shares Out 44.71M. 10 Day Average Volume 0.62M. Dividend -. Dividend Yield -. Beta 1.98. YTD % Change 193.24. Links CRDF StockTwits. Show Market Indexes. Detailed Chart. Chart Settings. About Candlesticks Basic Bullish Bearish. Default zoom . 125% rec. Find the latest Cardiff Oncology, Inc. (CRDF) stock quote, history, news and other vital information to help you with your stock trading and investing.Track Roku Inc (ROKU) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Cardiff Oncology Inc (CRDF) Reports Q4 and Full Year 2023 Financial Results. Mar 1. Cardiff Oncology, Inc. (CRDF) Q4 2023 Earnings Call Transcript. Feb 29. Cardiff Oncology, Inc. 2023 Q4 - Results - Earnings Call Presentation. Feb 29. Cardiff Oncology GAAP EPS of -$0.93 beats by $0.08, revenue of $0.48M beats by $0.2M.

Track Cardio Diagnostics Holdings Inc (CDIO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Cardiff Oncology, Inc. (NASDAQ:CRDF) Q1 2023 Earnings Call Transcript May 3, 2024 Cardiff Oncology, Inc. isn’t one of the 30 most popular stocks among hedge funds at the …

CRDF. -0.95% Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024. Track Crawford & Company (CRD) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Cardiff Oncology First Quarter 2024 Financial Results and Corporate Updates on May 2, 2024 at 4:30 p.m. ET/1:30 p.m. PT. Our lead asset is onvansertib, a PLK1 inhibitor that we are evaluating in combination with standard of care (SoC) therapeutics in clinical programs targeting indications with the greatest need for new treatment options. Stocktwits is the leading social platform for investors and traders to share ideas, insights and opinions about the stock, crypto and international markets. Join the Stocktwits community, follow your favorite symbols, get real-time quotes, news, earnings and fundamentals, and buy US stocks with ease.Track Immunovant Inc (IMVT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsBuild your trading network; Follow your favorite assets; Link Your Portfolio and become verifiedRevenue Per Employee. $15,250.00. Enterprise Value/EBITDA. 0.15. Home. Symbol. CRDF. Fundamentals. Get all financial information for Cardiff Oncology Inc (CRDF) including Market Capitalization, PE Ratio, EBITDA, EPS, previous close and open price, 52 week high & 52 week low, Beta and much more. Track CytoDyn Inc (CYDY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 29, 2024 Cardiff Oncology, Inc. 2024-02-06. SC 13G/A.Cardiff Oncology, Inc. (NASDAQ:CRDF) insiders placed bullish bets worth US$681k in the last 12 months. (Simply Wall St.) +6.48%. Mar-08-22 04:45PM. Cardiff Oncology Announces Upcoming Poster Presentations at the AACR Annual Meeting. Analyze Stocktwits Mentions for Cardiff Oncology and gain a competitive edge with unique and comprehensive information.

View the latest Cardiff Oncology Inc. (CRDF) stock price, news, historical charts, analyst ratings and financial information from WSJ.Track Aurora Cannabis Inc (ACB) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Find the latest Cardiff Oncology, Inc. (CRDF) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Find the latest AMC Entertainment Holdings, Inc. (AMC) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Instagram:https://instagram. kacey montoya last namelight skin guys with dreadsimagemate franklin countyradio flyer wagon wheels May 29, 2023 · CRDF is an oncology would-be pharma company currently supporting their ventures through one program: the polo-like kinase 1 (PLK1) inhibitor onvansertib. This enzyme controls DNA damage repair ... Welcome to CEPT Research and Development Foundation (CRDF). CRDF is a multidisciplinary think-do-tank promoted by CEPT University. Through CRDF, University engages actively in research projects, advisory assignments and capacity-building initiatives to solve critical problems in the built environment and improve people’s quality of life in … oconnell funeral home ellsworth wiis dale brisby a bull rider Ticker: CRDF CIK: 1213037 Form Type: 10-K Annual Report Accession Number: 0001628280-24-007948 Submitted to the SEC: Thu Feb 29 2024 4:00:21 PM EST Accepted by the SEC: Thu Feb 29 2024 Period: Sunday, December 31, 2023 Industry: Biological Products No Disgnostic Substances External Resources: Stock Quote Social …Ranker, an online publisher that turns crowdsourced lists and fan rankings into a data business, is now turning its attention to the world of streaming services. The company this w... is si still alive View the latest Cardiff Oncology Inc. (CRDF) stock price, news, historical charts, analyst ratings and financial information from WSJ.CRDF Latest Real Time Trades. Select time range to see more trades: Last 100 Trades. NLS Time (ET) NLS Price. NLS Share Volume. 16:00:04. $ 2.50. 1,360.Track CRISPR Therapeutics AG (CRSP) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors